Charged with illegal pharmaceutical sales – alleged earnings of 23 million

For at least five years, two men allegedly carried out illegal sales of pharmaceuticals and supplements, amassing millions. They are now facing charges at Söder...

FDA föreslår snabbspår för skräddarsydda behandlingar

Den amerikanska läkemedelsmyndigheten öppnar för en ny väg till marknaden för skräddarsydda genterapier. I ett utkast till vägledning signalerar myndigheten att...

FDA launches investigation into gene therapy following child death

The U.S. Food and Drug Administration (FDA) has initiated a safety investigation into Takeda’s Adzynma after reports that a child has died during treatment. The...

Southern Swedish company Aqilion develops drug for eosinophilic esophagitis

When Aqilion began developing a drug for eosinophilic esophagitis, the molecule was classified as an orphan drug. But the prevalence of the disease now appears ...

Vaccine project targeting congenital infection scrapped in late-stage trial – “Clearly disappointed”

Hope for the first vaccine against the world’s most common congenital infection has taken a serious hit

IVDR Reality Check: Are We Moving Fast Enough?

As of February 2025, around 1,500 IVDR certificates have been issued. But if an estimated 18,700 devices still need certification before the 2029 deadline, then...

Could an overly burdensome QMS be the organization’s own doing?

Although the above statement is intentionally somewhat provocative, it does hold a degree of truth. Organizations that are generally negative toward regulations...

Bioarctic om Leqembi-beskedet: ”Otroligt ledsna och besvikna”

På fredagen kom NT-rådets besked om att inte rekommendera alzheimerläkemedlet Leqembi (lecanemab) i Sverige. ”Jag kan lova att vi kommer utvärdera alla möjlighe...

Eli Lilly requests re-examination of Alzheimer's drug recommendation

Eli Lilly has requested that the EMA re-examine its opinion on the company's Alzheimer's drug, Kisunla, the agency announced on Friday.

Explore the possibilities of the new ZEISS METROTOM 800 320 kV

Free ZEISS webinar July 10, 9:00-9:45 AM and 5:00-5:45 PM.

Simple Material Analysis – From Classical to AI

Free webinar March 05, 2026, 09:00 - 09:45 AM / 05:00 - 05:45 PM (CET).

Sarah Lidé: ”Artificial intelligence must not replace authentic interactions”

Artificial intelligence must never become a replacement for authentic, even if messy, interactions with our fellow humankind, Sarah Lifé, Deputy CEO at Medicon ...

Many discontinue obesity medication – new study highlights the reasons

A new study maps out the most common reasons why patients choose to stop taking obesity medication prematurely. “Obesity medication discontinuation reverses hea...

Tools of Science

Supporting Investigator Initiated Clinical Studies—From Start to Finish

Many important clinical studies start with researchers – not pharmaceutical companies. In investigator initiated studies, pharmaceutical companies often support...

Quality assurance for research and development of medical devices

Overcome the hurdles of research, development, and QA lab environments within the regulated medical technology industry.

Ett år efter avbruten GPL-1-behandling – nästan hälften behöll sin vikt

Att avsluta medicinering med GLP‑1‑läkemedel behöver inte innebära att man går upp i vikt igen. I en stor amerikansk studie behöll nästan hälften av patienterna...

Ukraine war fuels rise of totally resistent bacteria

War-torn Ukraine is not just suffering from hostile attacks from a foreign aggressor, but also from the threat of a totally resistant and contagious bacteria.

Cost-efficient development of laboratory devices

8 ways to optimise development costs and speed up processes

New Horizons in Biologics & Bioprocessing incl. Advanced Therapies: Stockholm

Grönt ljus för Diamyds USA-patent

Diamyd Medical har fått klartecken för ett amerikanskt patent kopplat till bolagets diabeteskandidat retogatein.

From Image to Results

3D multiplexing spatial omics workflows in neuroscience.

How the Nobel discovery is used in drug development

Regulatory T cells keep the immune system in check, a discovery now awarded the 2025 Nobel Prize in Physiology or Medicine. Qiang Pan Hammarström explains how t...

Maximera robotens kapacitet med rätt EOAT-lösning

För att en robot ska prestera på topp krävs mer än bara avancerad programmering – rätt verktyg i robotens ände är avgörande. Med rätt End of Arm Tooling (EOAT) ...